Chronic Kidney Disease Biomarker Discovery and Validation Consortium (U01)

Post Date

January 14th 2009

Application Due Date

April 1st 2009

Funding Opportunity Number

RFA-DK-08-015

CFDA Number(s)

93.847

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Food and Nutrition
Health

Eligibility Categories

Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Tribally Controlled Colleges and Universities (TCCUs) .

Funding

• Estimated Total Funding:

  $2500000

• Award Range:

  $None - $500000

Grant Description

Purpose. This Funding Opportunity Announcement (FOA) issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), solicits grant applications from institutions/organizations that propose to discover or validate biomarkers for well-defined human chronic kidney diseases (CKD). The purpose of this initiative is to establish a multi-center consortium to discover new and/or validate already identified biomarkers for CKD. CKD is a major public health problem in the United States and in many other industrialized countries. The prevalence of Stage 1-4 CKD in the U.S. increased from 10.0% in 1988-1994 to 13.1% in 1999-2004. The burden of kidney failure, Stage 5 CKD, in the U.S. is also substantial and costly. Prevention, management, and regression of CKD are major goals of the NIDDK.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-08-015.html